Legal & General Group PLC Harrow Health, Inc. Transaction History

Legal & General Group PLC

$357 Billion
Q1 2025

A detailed history of Legal & General Group PLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 27,369 shares of HROW stock, worth $704,204. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,369

Previous 27,368 -0.0%

Holding current value

$704,204

Previous $918,000 20.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$22.22 - $36.67 $22 - $36	1 Added 0.0%	27,369 $728,000
Q4 2024 Feb 13, 2025	SELL	$33.39 - $57.5 $104,243 - $179,515	-3,122 Reduced 10.24%	27,368 $918,000
Q3 2024 Feb 28, 2025	BUY	$20.85 - $46.47 $729 - $1,626	35 Added 0.13%	27,403 $1.23 Million
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $564,284 - $1.26 Million	27,064 Added 789.96%	30,490 $1.37 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $211,150 - $456,928	-21,115 Reduced 86.04%	3,426 $71,000
Q1 2024 May 14, 2024	BUY	$9.3 - $13.23 $6,389 - $9,089	687 Added 2.88%	24,541 $324,000
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $2,160 - $3,400	154 Added 0.65%	23,854 $342,000
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $411,669 - $665,496	23,700 New	23,700 $451,000
Q2 2021 Aug 12, 2021	SELL	$6.68 - $11.07 $17,361 - $28,770	-2,599 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $1,295 - $2,283	-207 Reduced 7.38%	2,599 $18,000
Q3 2020 Nov 13, 2020	SELL	$4.71 - $7.36 $3,951 - $6,175	-839 Reduced 23.02%	2,806 $16,000
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $13,158 - $23,583	3,645 New	3,645 $19,000

Others Institutions Holding HROW

# of Institutions

175

Shares Held

21.1M

Call Options Held

330K

Put Options Held

670K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $697M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Harrow Health, Inc. Transaction History